11.1 Institutional Pharmacy Practice Sites (Rule 1140-04)

11.1 Institutional Pharmacy Practice Sites (Rule 1140-04)

Quick Answer: Under Tennessee Board of Pharmacy Rule Chapter 1140-04, an institutional pharmacy practice site provides pharmaceutical services to inpatients of a licensed healthcare facility. The Director of Pharmacy holds primary operational and legal accountability. When the pharmacy is closed and no pharmacist is on site or on call, physical entry is strictly limited to one designated registered nurse (RN) per shift to obtain urgent medications not stocked in floor supplies or night cabinets. The RN must record full withdrawal details and leave the container with an order copy for prompt retrospective pharmacist verification. In addition, institutions must maintain tamper-evident emergency kits labeled with the earliest expiring component, establish automatic stop orders for dangerous medications (controlled substances, antibiotics, anticoagulants) lacking a specified duration, and conduct monthly documented inspections of all drug storage areas across the entire institution, retaining records for at least 2 years.

---

1. Legal Framework and Statutory Definitions (Rule 1140-04-.01)

Tennessee Administrative Code Rules of the Tennessee Board of Pharmacy, Chapter 1140-04, establishes the operational, security, and dispensing mandates for Institutional Practice Sites across Tennessee. Understanding the exact statutory scope is essential for the MPJE:

• Institutional Facility: Any organization whose primary purpose is to provide a physical location for patient diagnosis, treatment, surgical care, and convalescence. This statutory classification includes:
  • General acute care hospitals
  • Psychiatric and behavioral health hospitals
  • Rehabilitation hospitals and spinal injury facilities
  • Specialty surgical hospitals and inpatient hospice pavilions
  • Mental health and developmental disability residential treatment centers
• Institutional Pharmacy Practice Site: The designated pharmacy physical space within or affiliated with an institutional facility where prescription drugs, devices, and related materials are procured, stored, compounded, repackaged, and dispensed for administration to inpatients.
• Inpatient Chart Order vs. Outpatient Prescription:
  • An inpatient chart order (medical chart order) is a lawful order entered directly into an institutional medical record by an authorized prescriber. It authorizes the administration of a drug to a hospitalized patient under medical supervision.
  • An inpatient chart order is not an outpatient prescription. It is exempt from outpatient container labeling rules (e.g., child-resistant caps under the Poison Prevention Packaging Act, retail auxiliary warning labels) because the medication is administered directly by licensed healthcare professionals.
  • Required Chart Order Data Elements: Patient full name, room and bed number, date of entry, drug name, strength, dosage form, explicit administration directions, and prescriber signature (electronic or manual).

┌─────────────────────────────────────────────────────────────────────────────┐
│                     INPATIENT MEDICATION ORDER FLOW                         │
├─────────────────────────────────────────────────────────────────────────────┤
│ 1. Licensed Prescriber enters Chart Order into CPOE / Medical Record       │
│    └─> Patient Name, Room/Bed, Drug, Strength, Dose, Route, Frequency       │
│                                                                             │
│ 2. Pharmacist Conducts Prospective Drug Utilization Review (DUR)            │
│    └─> Verifies allergy, dose appropriateness, organ function, interactions │
│    └─> Electronic Order Verification in Hospital Information System         │
│                                                                             │
│ 3. Product Dispensing / Automated Dispensing Cabinet (ADC) Profiling       │
│    └─> Order profile opens on nursing floor ADC (Pyxis / Omnicell)         │
│    └─> Barcode-verified nursing retrieval and administration                │
└─────────────────────────────────────────────────────────────────────────────┘

---

2. Director of Pharmacy: Legal Accountability & Operational Duties (Rule 1140-04-.02)

In every institutional pharmacy practice site licensed in Tennessee, overall professional, administrative, and regulatory responsibility rests with a single designated pharmacist: the Director of Pharmacy (institutional equivalent of a retail Pharmacist-in-Charge [PIC]).

Qualifications and Time Commitment

• The Director of Pharmacy must hold an active, unencumbered license as a pharmacist in the State of Tennessee.
• The Director of Pharmacy must be employed on a full-time basis (or part-time as formally approved by the Board based on bed capacity and institutional scope) to ensure continuous operational oversight.
• If the Director of Pharmacy resigns, is terminated, or permanently vacates the position, the Board of Pharmacy must be notified immediately, and a successor designated pursuant to Board change-of-PIC procedures under Rule 1140-01-.08.

Core Statutory Responsibilities

Under Rule 1140-04-.02, the Director of Pharmacy is legally responsible for:

1. Formulary and Procurement Management: Establishing and supervising drug procurement, specifications, receiving, and storage standards to prevent adulteration, counterfeit entry, or supply degradation.
2. Policy and Procedure Manual: Developing, maintaining, and annually reviewing a comprehensive written Policies and Procedures Manual governing all aspects of pharmaceutical services, distribution, sterile compounding, compounding safety, and security.
3. Distribution, Packaging & Compounding: Supervising all medication preparation, automated cabinet stocking, sterile IV admixture compounding (mandating strict adherence to USP <797> and USP <800>), and unit-dose repackaging.
4. Security & Access Control: Enforcing physical and electronic security systems that prevent unauthorized entry into the pharmacy practice site and drug storage areas 24 hours a day, 7 days a week.
5. Pharmacy & Therapeutics (P&T) Committee Participation: Serving as an active member of the facility's multidisciplinary P&T Committee, steering formulary decision-making, clinical protocols, adverse drug reaction (ADR) reporting, and automatic stop order policies.
6. Recordkeeping & Audit Compliance: Maintaining accurate, readily retrievable records of all drug transactions, controlled substance dispensing, waste logs, physical inventories, and monthly inspections for a minimum of two (2) years.

---

3. Physical Security & Closed-Pharmacy Access Protocols (Rule 1140-04-.03)

A core tenet of Tennessee institutional jurisprudence is that no person other than a licensed pharmacist may have unfettered, unescorted physical access to a pharmacy practice site. However, inpatient medical care is continuous, requiring emergency access to medications when the central pharmacy is closed during night shifts, holidays, or weekends.

The Institutional Security Baseline

• When a licensed pharmacist is on duty inside the pharmacy department, the pharmacy perimeter may remain open to authorized pharmacy personnel.
• When a pharmacist is not present (the pharmacy is closed), the department must be locked, alarmed, and secured against unauthorized entry.
• Routine supportive personnel (pharmacy technicians, interns, nursing assistants, or hospital security) are strictly prohibited from entering a closed pharmacy unaccompanied by a licensed pharmacist.

The After-Hours Medication Access Hierarchy

Tennessee law provides a strict, three-tiered access hierarchy to fulfill patient care needs when the institutional pharmacy is closed:

┌─────────────────────────────────────────────────────────────────────────────┐
│                 AFTER-HOURS MEDICATION ACCESS HIERARCHY                    │
├─────────────────────────────────────────────────────────────────────────────┤
│ TIER 1: Automated Dispensing Cabinets (ADCs) / Night Cabinets               │
│ • Decentralized profiled units located in nursing units or outside pharmacy │
│ • Stocked with pre-packaged emergency drugs and routine night doses        │
│ • Access authorized via clinical barcode scan and electronic profiling      │
├─────────────────────────────────────────────────────────────────────────────┤
│ TIER 2: Emergency Kits & Crash Carts                                        │
│ • Tamper-evident sealed boxes containing urgent life-support medications    │
│ • Readily available across clinical units for cardiac arrest / anaphylaxis  │
├─────────────────────────────────────────────────────────────────────────────┤
│ TIER 3: Physical Entry into Closed Pharmacy (Strict Statutory Exception)    │
│ • Permitted ONLY when medication is urgently needed, NOT in Tiers 1 or 2    │
│ • Pharmacist is NOT available on site or on call                            │
│ • Physical entry restricted to ONE DESIGNATED REGISTERED NURSE per shift    │
└─────────────────────────────────────────────────────────────────────────────┘

The Designated Registered Nurse (RN) Entry Exception

Under Board Rule 1140-04-.03, if a drug is urgently needed for a patient's immediate medical care, the drug is not available in floor stock, night cabinets, or emergency kits, and a pharmacist is not available on site or on call, physical entry into the closed pharmacy is permitted under strict legal restrictions:

1. Single Designated RN per Shift:
   • Access is restricted to exactly one (1) designated Registered Nurse (RN) per hospital shift.
   • The RN must be specifically selected by the Director of Nursing (DON) and approved by the Director of Pharmacy.
   • The designated RN must have completed prior documented education and training regarding pharmacy physical layout, drug storage, withdrawal logging, and safety protocols.
   • Exam Trap: A licensed practical nurse (LPN), certified nursing assistant (CNA), respiratory therapist, physician, or hospital security officer CANNOT enter the pharmacy to retrieve medications under this rule. Only the single designated RN is authorized.
2. Mandatory Removal Logging: At the time of entering and obtaining the drug, the designated RN must record the transaction in an official pharmacy logbook (or electronic access tracking system). The log must include all of the following data elements:
   • Patient's full name and hospital/medical record identification number
   • Drug name, chemical/brand entity, dosage form, and strength
   • Exact quantity of drug removed
   • Date and exact time of removal
   • Full physical signature (or authenticated electronic signature) of the designated RN
3. Container and Order Mandate (Physical Accountability):
   • The RN must remove only the quantity necessary to satisfy the immediate urgent medical need until the pharmacy reopens.
   • The RN must leave the manufacturer stock container, bulk bottle, or commercial package from which the drug was removed, together with a copy of the prescriber's chart order, on an intake counter or designated inspection tray inside the pharmacy.
4. Retrospective Pharmacist Verification:
   • A licensed pharmacist must retrospectively review, audit, and physically verify the RN's removal log, the retained stock container, and the chart order promptly upon the reopening of the pharmacy practice site (or within a policy-defined window, typically within 24 hours).

---

4. Emergency Kits, Crash Carts & Automated Dispensing Cabinets (Rule 1140-04-.04)

Emergency medications required for immediate resuscitation, cardiac arrest, intubation, and acute allergic emergencies must be maintained throughout institutional nursing floors and procedure suites.

Emergency Kits and Crash Carts

• P&T Committee Approval: The contents, dosage forms, strengths, and maximum quantities of medications stocked in crash carts and emergency kits must be formally established and reviewed annually by the P&T Committee in collaboration with the Director of Pharmacy.
• Tamper-Evident Indicator: Emergency kits must be securely sealed with a numbered, tamper-evident plastic break-away seal or secure electronic locking mechanism. The seal prevents unauthorized pilferage and instantly alerts staff if the kit has been opened.
• Exterior Expiration Labeling: The exterior surface of every emergency kit and crash cart must bear a prominent label that clearly displays:
  1. A comprehensive list of all medications contained within the kit (names, strengths, and quantities)
  2. The earliest expiration date of ANY individual drug component contained within the sealed kit
• Replenishment Protocol: When an emergency kit is opened or a seal is broken, nursing staff must immediately notify the pharmacy. The pharmacy staff must retrieve the kit, restock used items, inspect remaining contents for expiration, re-seal the kit with a new numbered tamper-evident seal, and update the exterior expiration label.

Floor Stock and Automated Dispensing Cabinets (ADCs)

• Floor Stock Approval: Routine floor stock medications (e.g., normal saline flushes, IV solutions, oral analgesics) placed on nursing units must be specifically approved by the Director of Pharmacy.
• Automated Dispensing Cabinets (Pyxis, Omnicell, AcuDose):
  • ADCs function as decentralized drug storage units operating under electronic profiling.
  • Restocking Requirements: Restocking must be conducted by a licensed pharmacist, pharmacy intern, or registered pharmacy technician under direct supervision, OR through an automated electronic barcode scanning system that verifies drug identity and strength before unlocking the designated pocket.
  • Controlled Substance Pockets: Controlled substances within ADCs must be maintained in single-dose individual locking pockets (matrix drawers prohibited for Schedule II unless strict electronic verification applies). Nursing withdrawals require witness verification for waste, and routine blind cycle counts are mandatory.

---

5. Automatic Stop Orders for Dangerous Medications (Rule 1140-04-.05)

In institutional inpatient practice, prescribers frequently order ongoing drug therapy without specifying a discrete calendar end-date. To protect hospitalized patients from severe drug toxicity, superinfections, bleeding, and chemical dependency resulting from forgotten or unmonitored orders, Tennessee law mandates automatic stop orders.

Mandatory Institutional Policy

Under Rule 1140-04-.05, an institutional facility must, in consultation with the medical staff and P&T Committee, develop and enforce a written Automatic Stop Order Policy:

The Automatic Stop Order Rule: Any inpatient medication order that is open-ended—meaning the prescriber did NOT specify a specific number of doses, a specific duration of therapy, or a stop date—is subject to an automatic administrative discontinuation after a predetermined time interval established by institutional policy.

High-Risk Drug Categories Subject to Automatic Stop

Tennessee Board rules specifically mandate automatic stop policies for high-risk, narrow-therapeutic, or toxic medications, including:

• Controlled Substances (Schedules II through V): Inpatient opioid infusions, scheduled oral narcotics, and benzodiazepines (typically subject to 48-hour to 72-hour automatic stop without re-evaluation).
• Systemic Antimicrobial Agents: Intravenous antibiotics, antifungals, and antivirals (commonly enforced with a 7-day or 10-day stop order to mandate clinical reassessment of culture results and stewardship review).
• Anticoagulants and Thrombolytics: Unfractionated heparin infusions, low-molecular-weight heparins (enoxaparin), and direct oral anticoagulants (DOACs).
• Cytotoxic Chemotherapy Agents: Parenteral antineoplastic medications.
• Sedatives and Hypnotics: Non-benzodiazepine sedatives and general anesthetic agents.

Clinical Notification Process

The institutional pharmacy's computerized order entry system must alert nursing staff and attending prescribers prior to automatic expiration (e.g., 24 hours before stop order execution). If the prescriber determines that continued therapy is medically indicated, they must affirmatively enter a new order or sign a renewal.

---

6. Documented Monthly Inspections of Drug Storage Areas (Rule 1140-04-.06)

To ensure drug stability, physical security, and sanitary compliance across the entire health system, Tennessee Board rules mandate regular, comprehensive audits of all non-pharmacy medication storage locations.

Inspection Mandate & Personnel

• Frequency: Documented inspections must be performed at least once every month (monthly).
• Auditor Qualifications: The inspection must be conducted by the Director of Pharmacy or a licensed pharmacist designee.

Physical Locations Subject to Monthly Inspection

The monthly inspection is not confined to the central pharmacy. It encompasses every single location within the institution where drugs, biologicals, or chemicals are stored, including:

• Nursing station medication rooms and clean utility rooms
• Decentralized Automated Dispensing Cabinets (ADCs) on all medical/surgical floors
• Emergency Department, Trauma Bays, and Urgent Care pavilions
• Intensive Care Units (Medical, Surgical, Cardiac, Neonatal, Pediatric ICUs)
• Operating Rooms (ORs), Anesthesia Workrooms, and Post-Anesthesia Care Units (PACU)
• Cardiac Catheterization Suites, Endoscopy Labs, and Interventional Radiology
• Emergency medication kits, intubation boxes, and crash carts across all floors
• Outpatient hospital-licensed clinics, physical therapy suites, and dialysis units

┌─────────────────────────────────────────────────────────────────────────────┐
│                     MONTHLY PHARMACY INSPECTION AUDIT                       │
├─────────────────────────────────────────────────────────────────────────────┤
│ Storage Temperatures │ Refrigerator (36°F–46°F) | Freezer (-13°F to 14°F)  │
│                      │ Ambient Room Temperature (68°F–77°F)                  │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Drug Integrity       │ Removal of expired, deteriorated, or recalled drugs  │
│                      │ Inspection of multi-dose vials (BUD 28 days)         │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Security Controls    │ All medication rooms, lockboxes, and ADCs secured    │
│                      │ Zero unauthorized personnel access                   │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Emergency Equipment  │ Crash cart seals intact; exterior expiration checked │
├──────────────────────┼──────────────────────────────────────────────────────┤
│ Retention & Filing   │ Written inspection reports maintained for 2 YEARS    │
└──────────────────────┴──────────────────────────────────────────────────────┘

Retention of Inspection Records

• All monthly inspection checklists, deficiency notices, and corrective action reports must be signed and dated by the inspecting pharmacist.
• Inspection records must be maintained at the institutional pharmacy practice site for at least two (2) years from the inspection date and made immediately available for Board of Pharmacy investigator review.

---

7. Inpatient Chart Orders vs. Community Prescriptions: Legal Comparison

---

8. Practical Exam Scenarios

Scenario 1: Closed-Pharmacy Emergency Retrieval

Case: At 2:00 AM on Sunday, a postoperative patient in a 120-bed hospital exhibits sudden severe respiratory failure requiring intravenous dantrolene. The central pharmacy is closed, and no pharmacist is on site or on call. The medication is not stocked in any nursing ADC or crash cart. The night nursing supervisor directs a licensed practical nurse (LPN) accompanied by a hospital security guard to enter the pharmacy and retrieve the medication. Legal Analysis: This action violates Tennessee Board Rule 1140-04-.03. When the pharmacy is closed and a pharmacist is unavailable, physical entry is statutorily restricted to one single designated Registered Nurse (RN) per shift who has received pharmacy-approved training. LPNs, security guards, and other hospital personnel are legally prohibited from entering the pharmacy. The designated RN must personally enter, record full removal data, and leave the stock vial and chart order copy for retrospective pharmacist verification.

Scenario 2: Crash Cart Seal Integrity & Earliest Expiry

Case: During a routine shift check on a medical floor, a staff nurse notices that the plastic break-away seal on the cardiac crash cart has broken. The nurse inspects the cart, sees all boxes intact, applies a replacement plastic zip-tie from the utility room, and documents the cart as "checked and secure." Legal Analysis: The nurse's action is unlawful under Rule 1140-04-.04. Once a tamper-evident seal is broken, nursing must immediately notify the pharmacy. Only pharmacy personnel may verify the contents, replenish used or expired components, document the audit, reseal the cart with an authorized numbered seal, and update the exterior label reflecting the earliest expiration date of any component.

Scenario 3: Automatic Stop Order on Unspecified Vancomycin

Case: An attending physician enters a chart order for "Vancomycin 1,000 mg IV every 12 hours" for an inpatient with suspected bacteremia, without indicating a duration of therapy or stop date. The hospital's P&T policy specifies a 7-day automatic stop for systemic antibiotics. On day 7, the pharmacy's computerized system dispatches an alert and discontinues the order. The physician files a complaint claiming the pharmacist altered a medical order without authorization. Legal Analysis: The pharmacist and pharmacy acted in full compliance with Tennessee Board Rule 1140-04-.05. Facilities are legally mandated to enforce automatic stop orders for open-ended antibiotic therapy. The physician's failure to specify a duration triggered the P&T-approved 7-day ceiling, requiring a clinical renewal order to proceed.